Merck KGaA Earnings Growth Beats Expectations — Update
The German life-science and chemicals company attributed earnings growth to a recovery of its life-science segment, cost discipline and lower spending on research and development following the ...
Merck KGaA Earnings Growth Beats Expectations
Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...
Morningstar3h
Merck KGaA Expects Sales at Lower End of Outlook Range After Third-Quarter Miss
Merck made an after-tax profit of 812 million euros compared ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
Germany’s Merck Expects Sales at Lower End of Outlook Range After Third-Quarter Miss
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Reuters4h
Merck KGaA Q3 earnings rise faster than expected on lower costs
FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly ...
Mersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...